The Cancer Therapeutics Training (CT2) Program is an NIH-funded training program in cancer therapeutic development. This program accepts both PhD and MD post-doctoral researchers.
Not accepting applications at this time. There will be more positions available next year. Please check back later!
If you are interested in applying, please contact Sara Campbell at firstname.lastname@example.org.
CT2 applicants must be United States citizens, noncitizen nationals or have been lawfully admitted for permanent residence by the time of their appointment.
Non-citizen nationals are people, who, although not citizens of the United States, owe permanent allegiance to the United States. They are generally people born in outlying territories of the United States (e.g., American Samoa and Swains Island). Individuals who have been lawfully admitted for permanent residence must have a currently valid Alien Registration Receipt Card (I-551) or other legal verification of such status. The NIH is no longer accepting the notarized permanent resident card, you must provide a notarized statement verifying possession of a valid permanent residency documentation.
Sorry, but individuals on temporary or student visas are
NOT eligible for CT2 support.
Prior Ruth L. Kirschstein-NRSA support
The National Research Service Award (now known as Ruth L. Kirschstein National Research Service Award) provides for a maximum of 3 years of post-doctoral funding. Since the CT2 program requires a two-year, NRSA-eligible commitment,
eligibility for the program requires that you have had no more than 1 year of prior NRSA post-doctoral support.
All CT2 applicants must identify a faculty mentor who is a Cancer Center member prior to having their application reviewed by the Executive Committee. Please
contact the mentor in whose laboratory you wish to complete your research prior to submitting your application. A letter from your mentor expressing interest in having you join his/her group is required to move your application forward.
However, new CT2 faculty mentors are permitted to be appointed at any point during the grant year, provided that they meet the specific criteria: have an appointment as a cancer center member, are conducting an independent program in cancer research, have an independently generated R01 or equivalent peer-reviewed funding related to cancer research and therapeutics (preferrably an NCI grant) with the likelihood of long-term stability, and have an excellent history of providing quality training. This can be confirmed by presenting the NIH biosketch.
If you would like to be considered for a training position, please identify a faculty mentor and submit the following to email@example.com:
- Cancer Therapeutics Training Program Application (with faculty mentor identified)
- Curriculum Vitae (please include ALL authors on publications)
- A one-page personal statement describing your past research or medical experience, why you are interested in the program, and your future goals
- Proof of Citizenship
- 3 formal letters of recommendation (should be PDF version, on letterhead, with signature)
- A letter from your chosen mentor (this can substitute for one of the letters of recommendation)
Please send application and other materials via e-mail (preferred) or by standard mail to:
The Cancer Therapeutics Training Program
Program Administrator, Sara Campbell
UC San Diego Moores Cancer Center
3855 Health Sciences Drive, #0819
La Jolla, California, USA 92093-0819
For further information, please contact the CT2 Program Administrator, Sara Campbell, via email at firstname.lastname@example.org or telephone at 858-822-1110.